New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company ...

--Semper Paratus Acquisition Corporation, a publicly-traded special purpose acquisition company, today announced that it has filed a supplement to its definitive proxy statement/prospectus dated ...

In connection with the Merger Agreement and the Transaction, Semper Parahas filed relevant materials with the Securities and Exchange Commission, including a registration statement on Form S-4 ...

New York, NY, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Inc (“Tevogen Bio”), an advanced-stage specialty immunotherapy biotech pioneer and Semper Paratus Acquisi ...

Contacts: Semper Paratus Acquisition Corporation Philippe J. Kurzweil Chief Financial Officer and Secretary Tel: (646) 807-8832 Email: [email protected] ...

New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced ...

New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced ...

Ad hoc-Mitteilungen: Nachrichten»Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc Push ...

Semper Paratus' investors and shareholders will also be able to obtain copies of the Proxy Statement/Prospectus, and other documents filed with the SEC that will be incorporated by reference ...